The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global LFA-based Cardiac Market Research Report 2025
Synopsis
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The global LFA-based Cardiac market was valued at US$ 3595.4 million in 2023 and is anticipated to reach US$ 6160.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.
Report Scope
The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lateral Flow Assay is a simple to use diagnostic device used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The global LFA-based Cardiac market was valued at US$ 3595.4 million in 2023 and is anticipated to reach US$ 6160.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The industry's leading producers are Roche, Abbott and Siemens, with revenues of 26.24%, 16.11% and 11.04% respectively in 2019.
This report aims to provide a comprehensive presentation of the global market for LFA-based Cardiac, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LFA-based Cardiac.
Report Scope
The LFA-based Cardiac market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global LFA-based Cardiac market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LFA-based Cardiac companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
Segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Segment by Application
Laboratory Testing
Point-of-care Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LFA-based Cardiac Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Troponin I
1.2.3 Troponin T
1.2.4 CK-MB
1.2.5 Myoglobin
1.2.6 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Market Perspective (2019-2030)
2.2 LFA-based Cardiac Growth Trends by Region
2.2.1 Global LFA-based Cardiac Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 LFA-based Cardiac Historic Market Size by Region (2019-2024)
2.2.3 LFA-based Cardiac Forecasted Market Size by Region (2025-2030)
2.3 LFA-based Cardiac Market Dynamics
2.3.1 LFA-based Cardiac Industry Trends
2.3.2 LFA-based Cardiac Market Drivers
2.3.3 LFA-based Cardiac Market Challenges
2.3.4 LFA-based Cardiac Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LFA-based Cardiac Players by Revenue
3.1.1 Global Top LFA-based Cardiac Players by Revenue (2019-2024)
3.1.2 Global LFA-based Cardiac Revenue Market Share by Players (2019-2024)
3.2 Global LFA-based Cardiac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by LFA-based Cardiac Revenue
3.4 Global LFA-based Cardiac Market Concentration Ratio
3.4.1 Global LFA-based Cardiac Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Revenue in 2023
3.5 LFA-based Cardiac Key Players Head office and Area Served
3.6 Key Players LFA-based Cardiac Product Solution and Service
3.7 Date of Enter into LFA-based Cardiac Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Breakdown Data by Type
4.1 Global LFA-based Cardiac Historic Market Size by Type (2019-2024)
4.2 Global LFA-based Cardiac Forecasted Market Size by Type (2025-2030)
5 LFA-based Cardiac Breakdown Data by Application
5.1 Global LFA-based Cardiac Historic Market Size by Application (2019-2024)
5.2 Global LFA-based Cardiac Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America LFA-based Cardiac Market Size (2019-2030)
6.2 North America LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America LFA-based Cardiac Market Size by Country (2019-2024)
6.4 North America LFA-based Cardiac Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LFA-based Cardiac Market Size (2019-2030)
7.2 Europe LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe LFA-based Cardiac Market Size by Country (2019-2024)
7.4 Europe LFA-based Cardiac Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Market Size (2019-2030)
8.2 Asia-Pacific LFA-based Cardiac Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific LFA-based Cardiac Market Size by Region (2019-2024)
8.4 Asia-Pacific LFA-based Cardiac Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LFA-based Cardiac Market Size (2019-2030)
9.2 Latin America LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America LFA-based Cardiac Market Size by Country (2019-2024)
9.4 Latin America LFA-based Cardiac Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Market Size (2019-2030)
10.2 Middle East & Africa LFA-based Cardiac Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa LFA-based Cardiac Market Size by Country (2019-2024)
10.4 Middle East & Africa LFA-based Cardiac Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche LFA-based Cardiac Introduction
11.1.4 Roche Revenue in LFA-based Cardiac Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott LFA-based Cardiac Introduction
11.2.4 Abbott Revenue in LFA-based Cardiac Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens LFA-based Cardiac Introduction
11.3.4 Siemens Revenue in LFA-based Cardiac Business (2019-2024)
11.3.5 Siemens Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher LFA-based Cardiac Introduction
11.4.4 Danaher Revenue in LFA-based Cardiac Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories LFA-based Cardiac Introduction
11.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 BioMérieux
11.6.1 BioMérieux Company Detail
11.6.2 BioMérieux Business Overview
11.6.3 BioMérieux LFA-based Cardiac Introduction
11.6.4 BioMérieux Revenue in LFA-based Cardiac Business (2019-2024)
11.6.5 BioMérieux Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher LFA-based Cardiac Introduction
11.7.4 Thermo Fisher Revenue in LFA-based Cardiac Business (2019-2024)
11.7.5 Thermo Fisher Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2019-2024)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 LSI Medience Corporation
11.9.1 LSI Medience Corporation Company Detail
11.9.2 LSI Medience Corporation Business Overview
11.9.3 LSI Medience Corporation LFA-based Cardiac Introduction
11.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Business (2019-2024)
11.9.5 LSI Medience Corporation Recent Development
11.10 Randox laboratories
11.10.1 Randox laboratories Company Detail
11.10.2 Randox laboratories Business Overview
11.10.3 Randox laboratories LFA-based Cardiac Introduction
11.10.4 Randox laboratories Revenue in LFA-based Cardiac Business (2019-2024)
11.10.5 Randox laboratories Recent Development
11.11 Wondfo Biotech
11.11.1 Wondfo Biotech Company Detail
11.11.2 Wondfo Biotech Business Overview
11.11.3 Wondfo Biotech LFA-based Cardiac Introduction
11.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Business (2019-2024)
11.11.5 Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global LFA-based Cardiac Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Troponin I
Table 3. Key Players of Troponin T
Table 4. Key Players of CK-MB
Table 5. Key Players of Myoglobin
Table 6. Key Players of Others
Table 7. Global LFA-based Cardiac Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global LFA-based Cardiac Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global LFA-based Cardiac Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global LFA-based Cardiac Market Share by Region (2019-2024)
Table 11. Global LFA-based Cardiac Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global LFA-based Cardiac Market Share by Region (2025-2030)
Table 13. LFA-based Cardiac Market Trends
Table 14. LFA-based Cardiac Market Drivers
Table 15. LFA-based Cardiac Market Challenges
Table 16. LFA-based Cardiac Market Restraints
Table 17. Global LFA-based Cardiac Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global LFA-based Cardiac Market Share by Players (2019-2024)
Table 19. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2023)
Table 20. Ranking of Global Top LFA-based Cardiac Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by LFA-based Cardiac Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players LFA-based Cardiac Product Solution and Service
Table 24. Date of Enter into LFA-based Cardiac Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global LFA-based Cardiac Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global LFA-based Cardiac Revenue Market Share by Type (2019-2024)
Table 28. Global LFA-based Cardiac Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global LFA-based Cardiac Revenue Market Share by Type (2025-2030)
Table 30. Global LFA-based Cardiac Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global LFA-based Cardiac Revenue Market Share by Application (2019-2024)
Table 32. Global LFA-based Cardiac Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global LFA-based Cardiac Revenue Market Share by Application (2025-2030)
Table 34. North America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific LFA-based Cardiac Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific LFA-based Cardiac Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific LFA-based Cardiac Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa LFA-based Cardiac Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa LFA-based Cardiac Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa LFA-based Cardiac Market Size by Country (2025-2030) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche LFA-based Cardiac Product
Table 52. Roche Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Abbott Company Detail
Table 55. Abbott Business Overview
Table 56. Abbott LFA-based Cardiac Product
Table 57. Abbott Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 58. Abbott Recent Development
Table 59. Siemens Company Detail
Table 60. Siemens Business Overview
Table 61. Siemens LFA-based Cardiac Product
Table 62. Siemens Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 63. Siemens Recent Development
Table 64. Danaher Company Detail
Table 65. Danaher Business Overview
Table 66. Danaher LFA-based Cardiac Product
Table 67. Danaher Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 68. Danaher Recent Development
Table 69. Bio-Rad Laboratories Company Detail
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories LFA-based Cardiac Product
Table 72. Bio-Rad Laboratories Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 73. Bio-Rad Laboratories Recent Development
Table 74. BioMérieux Company Detail
Table 75. BioMérieux Business Overview
Table 76. BioMérieux LFA-based Cardiac Product
Table 77. BioMérieux Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 78. BioMérieux Recent Development
Table 79. Thermo Fisher Company Detail
Table 80. Thermo Fisher Business Overview
Table 81. Thermo Fisher LFA-based Cardiac Product
Table 82. Thermo Fisher Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 83. Thermo Fisher Recent Development
Table 84. Ortho Clinical Diagnostics Company Detail
Table 85. Ortho Clinical Diagnostics Business Overview
Table 86. Ortho Clinical Diagnostics LFA-based Cardiac Product
Table 87. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 88. Ortho Clinical Diagnostics Recent Development
Table 89. LSI Medience Corporation Company Detail
Table 90. LSI Medience Corporation Business Overview
Table 91. LSI Medience Corporation LFA-based Cardiac Product
Table 92. LSI Medience Corporation Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 93. LSI Medience Corporation Recent Development
Table 94. Randox laboratories Company Detail
Table 95. Randox laboratories Business Overview
Table 96. Randox laboratories LFA-based Cardiac Product
Table 97. Randox laboratories Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 98. Randox laboratories Recent Development
Table 99. Wondfo Biotech Company Detail
Table 100. Wondfo Biotech Business Overview
Table 101. Wondfo Biotech LFA-based Cardiac Product
Table 102. Wondfo Biotech Revenue in LFA-based Cardiac Business (2019-2024) & (US$ Million)
Table 103. Wondfo Biotech Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global LFA-based Cardiac Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global LFA-based Cardiac Market Share by Type: 2023 VS 2030
Figure 3. Troponin I Features
Figure 4. Troponin T Features
Figure 5. CK-MB Features
Figure 6. Myoglobin Features
Figure 7. Others Features
Figure 8. Global LFA-based Cardiac Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global LFA-based Cardiac Market Share by Application: 2023 VS 2030
Figure 10. Laboratory Testing Case Studies
Figure 11. Point-of-care Testing Case Studies
Figure 12. LFA-based Cardiac Report Years Considered
Figure 13. Global LFA-based Cardiac Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global LFA-based Cardiac Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global LFA-based Cardiac Market Share by Region: 2023 VS 2030
Figure 16. Global LFA-based Cardiac Market Share by Players in 2023
Figure 17. Global Top LFA-based Cardiac Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by LFA-based Cardiac Revenue in 2023
Figure 19. North America LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America LFA-based Cardiac Market Share by Country (2019-2030)
Figure 21. United States LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe LFA-based Cardiac Market Share by Country (2019-2030)
Figure 25. Germany LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific LFA-based Cardiac Market Share by Region (2019-2030)
Figure 33. China LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America LFA-based Cardiac Market Share by Country (2019-2030)
Figure 41. Mexico LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa LFA-based Cardiac Market Share by Country (2019-2030)
Figure 45. Turkey LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia LFA-based Cardiac Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 48. Abbott Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 49. Siemens Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 50. Danaher Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 52. BioMérieux Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 53. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 54. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 55. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 56. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 57. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
